Tomohiko Maehama

11PUBLICATIONS
19CO-AUTHORS
Molecular targetsCell development, proliferation and deathCancer geneticsMedical infection agents (incl. prions)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 17, 2026
YAP1 induces hepatocellular carcinoma via DNA demethylation rather than by canonical driver gene mutations.

|Apr 21, 2026
SAMD4 represses VGLL4 mRNA to activate TEAD and promote cancer progression.

|Feb 10, 2023
Nucleolar stress: Molecular mechanisms and related human diseases.

Tomohiko Maehama, Miki Nishio, Junji Otani

|Sep 02, 2022
N-(3,4-dimethoxyphenethyl)-6-methyl-2,3,4,9-tetrahydro-1H-carbazol-1-amine inhibits bladder cancer progression by suppressing YAP1/TAZ.

Yusuke Shiraishi, Tomohiko Maehama, Miki Nishio

|Sep 02, 2022
The TIGD5 gene located in 8q24 and frequently amplified in ovarian cancers is a tumor suppressor.

Yuntao Dai, Tetsuya Kawaguchi, Miki Nishio

|Jul 21, 2021
Alantolactone is a natural product that potently inhibits YAP1/TAZ through promotion of reactive oxygen species accumulation.

Keisuke Nakatani, Tomohiko Maehama, Miki Nishio

Pageof 2

Frequent Collaborators

7 joint publications

Akira Suzuki

2 joint publications

Hiroshi Nishina

1 joint publications

Hirofumi Omori

1 joint publications

Muneyuki Masuda